Subgroups
Bayer AG (Holding Company)
-
Thursday - May 16, 2013
Strategic move to strengthen Consumer Care business:
Bayer to acquire Steigerwald Arzneimittelwerk GmbH
Transaction includes Iberogast® and Laif® brands » more
-
Wednesday - May 15, 2013
Dr. Herbert Heitmann to be new Head of Communications and Government Relations at Bayer » more
-
Tuesday - May 14, 2013
Bayer Head of Communications will join soccer team
Michael Schade will become Managing Director of Bayer 04 Leverkusen » more
-
Tuesday - May 7, 2013
Not intended for UK Media
Bayer commences cash tender offer for all outstanding shares of Conceptus, Inc. » more
-
Tuesday - May 7, 2013
Sustainable Development Report 2012:
Bayer documents economic, social and ecological performance
Bayer CEO Dekkers: “Innovation and sustainability are the driving force behind our business success” / Integrated reporting from 2014 » more
-
Monday - April 29, 2013
Not intended for UK media - Strategic expansion of Women’s Health business:
Bayer to acquire Conceptus, Inc.
Adds Essure®, the only non-surgical permanent birth control method, to Bayer’s contraception portfolio » more
-
Friday - April 26, 2013
Annual Stockholders' Meeting 2013 » more
-
Friday - April 26, 2013
Dr. Marijn Dekkers at the Annual Stockholders’ Meeting of Bayer AG:
“Bayer is a world-class innovation company”
2012 operationally a very successful year / Highest sales in the company’s 150-year history / Proposal to raise dividend for 2012 to EUR 1.90 per share / Employees to benefit from the company’s success with bonuses totaling over EUR 700 million / Life Sciences off to a good start in anniversary year » more
-
Thursday - April 25, 2013
Bayer helps victims of earthquake in China
Monetary and material donations totaling around EUR 1.1 million » more
-
Thursday - April 25, 2013
First quarter of 2013:
Bayer: Life Sciences off to a good start in anniversary year
New pharmaceutical products spur growth at HealthCare, continuing strong development at CropScience, cost pressure at MaterialScience / Group sales up 2.1 percent to EUR 10,266 million / EBIT improves by 8.6 percent to EUR 1,771 million / EBITDA before special items increased by 0.4 percent to EUR 2,453 million / Net income rises 11.5 percent to EUR 1,160 million / Gratifying development in Emerging Markets / Group outlook for 2013 confirmed » more
-
Thursday - March 21, 2013
Press conference: opening ceremony of the Bayer art exhibition
From Beckmann to Warhol – Art of the 20th and 21st centuries – The Bayer Collection / Martin-Gropius-Bau, March 22 to June 9, 2013 » more
-
Thursday - February 28, 2013
Financial News Conference
Full Year 2012 Results » more
-
Thursday - February 28, 2013
New products create optimism for the future
Bayer: continuing growth momentum
Group targets achieved in 2012 – sales and earnings before special items increase in all subgroups / Sales increase by 8.8 percent to EUR 39,760 million / EBIT EUR 3,960 million (minus 4.6 percent) – Net income EUR 2,446 million (minus 1.0 percent) / Further accounting measures for legal claims / EBITDA before special items rises by 8.8 percent to EUR 8,284 million / Core earnings per share improve by 10.8 percent to EUR 5.35 / Encouraging growth in the emerging markets / Steady progress with innovation pipeline strengthens life-science businesses / Forecast for anniversary year 2013: continuing record development » more
-
Tuesday - February 26, 2013
Bayer proposes dividend increase to EUR 1.90 per share for 2012
Payout up 15 percent to EUR 1,571 million » more
-
Friday - February 22, 2013
New award from the Bayer Science & Education Foundation:
Bayer Thrombosis Research Award 2013 for Dr. Krystin Krauel
Research scientist at Ernst-Moritz-Arndt University Greifswald honored for her work in the field of antibacterial host defenses » more
-
Friday - January 25, 2013
Bayer foundation cooperates with Humboldt Foundation
EUR 3 million for new Humboldt-Bayer research fellowships
Financing for 10 post-doctoral fellowships a year through 2018 / Focus on the life sciences, chemistry and pharmacy » more
-
Wednesday - January 23, 2013
Dr. Jörg Reinhardt to leave Bayer HealthCare » more
-
Thursday - January 10, 2013
Awards from the Bayer Science & Education Foundation
Bayer Early Excellence in Science Award 2012: EUR 30,000 for young research scientists
Dr. Christiane Opitz (German Cancer Research Center, Heidelberg) wins the „Biology“ category / Dr. Nuno Maulide (Max Planck Institut für Kohlenforschung, Mühlheim an der Ruhr) takes the „Chemistry“ award / Dr. Volker Presser (Leibniz Institute for New Materials, Saarbrücken) awarded prize in the „Materials“ field » more
-
Wednesday - December 19, 2012
Bayer optimizes its use of liquidity
Group contributes EUR 1 billion to Bayer Pension Trust » more
-
Friday - December 14, 2012
Michael Koenig appointed to the Bayer Board of Management
Dr. Richard Pott to retire effective June 1, 2013 » more
Copyright @ Bayer AG